Mark Richards

26 Jun, 2025

Mark has 15 years of sales experience in life sciences, including 8 years in regulatory solutions.

Other Related Articles

EMA Roadmap Update: PMS Capabilities and the End of the Legacy Era

01 Apr, 2026

Expanded Access Approval : Balancing Urgency and Oversight in Regulatory Affairs

26 Mar, 2026

How to Reduce Notified Body Review Cycles Through Better Clinical Documentation

18 Mar, 2026

The Great Convergence — Why 2026 is the Year Regulatory “Records” Die

10 Mar, 2026

Raw Material Compliance in Pharmaceuticals: Naming, Pharmacopeial Grade, and Safety Requirements

24 Feb, 2026

EMA Upgrades xEVMPD Web Interface

19 Feb, 2026

Raw Material Compliance in Pharmaceuticals

13 Feb, 2026

How FDA Reviews Cell & Gene Therapies: A Deep-Dive Regulatory Guide

06 Feb, 2026

View All